|
Market Closed -
Nasdaq
23:00:00 12/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.2071 USD | -5.78% |
|
-3.58% | -58.41% |
| Market Cap | 11.25M 9.75M 9.14M 8.33M 15.67M 1.07B 15.91M 107M 42M 537M 42.26M 41.34M 1.79B | P/E 2026 * |
20.7x | P/E 2027 * | 2.96x |
|---|---|---|---|---|---|
| Enterprise Value | 11.25M 9.75M 9.14M 8.33M 15.67M 1.07B 15.91M 107M 42M 537M 42.26M 41.34M 1.79B | EV / Sales 2026 * |
0.13x | EV / Sales 2027 * | 0.1x |
| Free-Float |
63.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.78% | ||
| 1 week | -3.58% | ||
| Current month | -3.94% | ||
| 1 month | -29.24% | ||
| 3 months | -32.61% | ||
| 6 months | -44.51% | ||
| Current year | -58.41% |
| 1 week | 0.2 |  | 0.25 |
| 1 month | 0.18 | | 0.31 |
| Current year | 0.16 | | 0.59 |
| 1 year | 0.16 | | 1.32 |
| 3 years | 0.16 | | 2.05 |
| 5 years | 0.16 | | 150 |
| 10 years | 0.16 | | 312.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 26/02/2016 |
Georgios Terzis
DFI | Director of Finance/CFO | 43 | 11/11/2020 |
| Chief Operating Officer | 56 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 13/01/2014 | |
Grigorios Siokas
CHM | Chairman | 60 | 26/02/2016 |
John Hoidas
BRD | Director/Board Member | 59 | 18/11/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/30/26 A | Buy | Chief Executive Officer | 349,825 | 1.1578% | ||
| 7/29/26 A | Free | Chief Financial Officer | 328,407 | 1.0869% | ||
| 7/29/26 A | Buy | Chief Executive Officer | 766,284 | 2.5362% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.78% | -3.58% | -73.99% | -84.31% | 11.25M | |
| -2.55% | +0.17% | +33.34% | +99.68% | 102B | |
| -2.54% | -2.12% | +60.05% | +153.47% | 54.46B | |
| +0.68% | -0.33% | +4.20% | +270.19% | 24.09B | |
| -0.78% | +0.61% | -12.93% | -14.11% | 8.23B | |
| -1.04% | +5.66% | -30.42% | -25.18% | 7.67B | |
| -0.06% | -2.11% | -13.40% | -21.59% | 6.66B | |
| -0.12% | +0.24% | +16.98% | +17.37% | 6.19B | |
| +0.37% | -3.64% | -6.16% | +18.85% | 4.94B | |
| -0.59% | +2.65% | -5.97% | -4.99% | 3.73B | |
| Average | -1.24% | -0.50% | -2.83% | +40.94% | 21.84B | |
| Weighted average by Cap. | -1.83% | -0.44% | +29.35% | +113.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 84.3M 73.04M 68.43M 62.42M 117M 8.04B 119M 805M 315M 4.03B 317M 310M 13.42B | 111M 96M 89.94M 82.04M 154M 10.57B 157M 1.06B 414M 5.29B 416M 407M 17.64B |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | $0.2071 | -5.78% | 1,961,585 |
| 11/08/26 | $0.2198 | -1.66% | 1,890,531 |
| 10/08/26 | $0.2235 | -4.08% | 3,862,758 |
| 07/08/26 | $0.2330 | +5.43% | 5,742,937 |
| 06/08/26 | $0.2210 | +2.89% | 2,624,814 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
